Duchenne Muscular Dystrophy Part 1: What We Know Now
Presented by Claudia Senesac
12-Month Subscription
Unlimited access to:
- Thousands of CE Courses
- Patient Education
- Home Exercise Program
- And more
Meet your instructor
Claudia Senesac
Claudia Senesac is a clinical associate professor at University of Florida in the Doctor of Physical Therapy department. Her teaching responsibilities include functional anatomy dissection and pediatrics in physical therapy. She has over 37 years of pediatric clinical experience. She has been the owner and administrator of a…
Chapters & learning objectives
1. What We Know Now
The chapter will provide foundational background information to enhance the participants' understanding of DMD. Signs and symptoms of this disease will be detailed and the process of differential diagnosis reviewed. The most common medications and supplements will be covered.
2. Identified Biomarkers
Identified biomarkers have helped to further our understanding of this disease and monitor disease progression. Selected biomarkers have been developed and are emerging as outcome measures in research.
3. Research and Understanding DMD
Longitudinal research studies shed light on our current understanding of DMD. Correlations of multiple outcomes help make predictions for function. Predictions of function allow for planning for the future.
